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Abstract
Background: There is consensus on the importance of early detection and treatment of high blood pressure.
Dental care is one of few medical services to which a considerable proportion of the general population comes for
regular check-ups. We tested the effects of blood pressure screening in dental care centres with subsequent work-
up of subjects screening positive in primary health care (PHCC).
Methods: Altogether 1,149 subjects 40-65 years old or 20-39 years old with body mass index >25, and with no
previously known hypertension, who came for a dental examination had their blood pressure measured with an
Omron M4
® automatic blood pressure reading device. Subjects with systolic blood pressure readings above
160 mmHg or diastolic above 90 mmHg were referred to their PHCC for a check up. Outcome data were obtained
by scrutiny of PHCC and hospital patient records for hypertension diagnoses during the three years following
screening.
Results: 237 (20.6%) subjects screened positive. Of these, 230 (97.1%) came to their PHCC within the 3-year follow-
up period, as compared with 695 (76.2%) of those who screened negative (p < 0.0001). Of those who screened
positive, 76 (32.1%) received a diagnosis of hypertension, as compared with 26 (2.9%) of those who screened
negative. Sensitivity was 79.1%, specificity 84.8% and positive predictive value 30.1%. The number of subjects
needed to screen to find one case of hypertension was 18.
Conclusions: Co-operation between dental and primary care for blood pressure screening and work-up appears to
be an effective way of detecting previously unknown hypertension.
Background
Hypertension is a global health problem. It has been
estimated that approximately 1.8 million (27%) adults in
Sweden may have high blood pressure, according to the
World Health Organization criteria [1]. The conse-
quences of non-treated high blood pressure are well
known and include increased risk of developing heart
disease, stroke, kidney disease and retinopathy [2].
There is a general consensus that the best way to avoid
such problems is early detection and treatment of the
high blood pressure, before organ damage has occurred.
Many subjects with hypertension are unaware of their
condition. Most incidents of hypertension are detected
at primary health care, usually en passant when patients
seek care for other conditions, a kind of non-systematic
opportunistic screening.
In industrialised countries, dental care is usually the
only public health care organisation to which healthy
people come for regular checkups, usually at least once
every second year [3,4]. Patients only come to almost all
other health care organizations for consultations when
they are ill or have a health complaint. Thus the dental
service might be one of the most suitable health care
organisations for systematic opportunistic screening of
healthy subjects as well as for subjects with dental dis-
ease. However, one prerequisite for success is a multi-
disciplinary approach with cooperation between the
dental services and primary health care services for clin-
ical work-ups of subjects screening positive [4].
The aim of this cooperative project between the dental
and primary healthcare service was to test the efficacy of
blood pressure screening in the dental service with sub-
sequent workup in primary care.
* Correspondence: sevek.engstrom@pubcare.uu.se
1Uppsala University, Department of Public Health and Caring Sciences,
Family Medicine and Clinical Epidemiology Section, Uppsala, Sweden
Full list of author information is available at the end of the article
Engström et al. BMC Public Health 2011, 11:194
http://www.biomedcentral.com/1471-2458/11/194
© 2011 Engström et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Methods
Setting
The overwhelming part of Swedish medical care is run
by the counties, which have a similar legislative position
as the US states. They are responsible for health care
within their area, either by County council operated
health care units (at the time of the study the vast
majority) or by subcontracted private units. Regarding
dental health care the situation is similar, except that
approximately half of the units are County council oper-
ated and the remaining are private units, subcontracted
by the central government. However, all units, whether
County council operated or private subcontractor, follow
the same regulations.
The blood pressure screening study was performed at
two County council operated dental clinics located in a
small municipality (population 12,000) in the northern
part of Gävleborg County, Sweden (population 277,000),
approximately 250 kilometres north of Stockholm. The
two primary health care centres (PHCC) in the munici-
pality, both County council operated, were partners in
the project and were responsible for calibration of the
blood pressure reading device used and for blood pres-
sure checkups for patients screening positive.
Study population
At the two dental clinics, all consecutive patients aged
20-65 scheduled for a regular check up from 15 May
2003 to 20 December 2005 and living within the muni-
cipality were invited by letter to participate in the study.
The screening procedure was performed at the dental
appointment before the dental examination. Participants
were asked to state their height and weight and whether
they had a known hypertension. Patients who had no
known hypertension and who were in the age range
20-39 with a body mass index (BMI) >25 or in the age
range 40-65 regardless of BMI were eligible for screen-
ing. Of the 1,791 eligible subjects 1,149 (64%) agreed to
have their blood pressure measured. The agreement rate
was highly age dependent as shown in Figure 1.
Data collection
Blood pressure was measured in a sitting position, in the
left arm, after 5 minutes’ rest, with an automatic blood
pressure reading device (Omron M4
®). If the systolic
blood pressure reading was above 160 mmHg or the dia-
stolic above 90 mmHg a second reading was taken after
the dental examination and the lowest recorded value
was used as the screening blood pressure. Data measured
at the dental clinics were registered in pre-prepared pro-
tocols and entered into the study database. Subjects with
screening systolic blood pressure >160 or a diastolic
blood pressure >90 were asked for a referral permission
(all accepted). A copy of the dental service protocol was
sent as referral document for work up to the subject’s
PHCC, where an appointment was arranged.
Data on all appointments at the two PHCCs for the
complete study population, regardless of screening
result, for the three years preceding and the three years
following the screening appointment were obtained
from the PHCC medical records data base. To check for
completeness, appointment logbooks were also scruti-
nized. Data included appointment date, category of care
provider (GP, district nurse, hypertension nurse, phy-
siotherapist, etc.), and for GP and hypertension nurse
appointments, diagnoses. The latter were coded accord-
ing to the International Classification of Diseases [5]
and were also given in plain text. In addition, discharge
diagnoses after hospital admissions within the three
years following screening were scrutinized for hyperten-
sion diagnoses. Moreover, the first PHCC blood pres-
sure reading for subjects referred from the dental clinics
to the PHCCs was obtained.
Three outcomes were used in this study. The first was
whether the referred subjects actually came to the
PHCC for follow up, the second whether blood pressure
was measured, and the third whether a hypertension
diagnosis was established during the first three years
after screening. The presence of a hypertension diagno-
sis during the three years preceding screening was also
sought for an additional check of hypertension status at
the time of screening.
All participants gave their written informed consent.
The study was performed in accordance with the Hel-
sinki Declaration and was approved several times during
the data collection process by the Research Ethics Com-
mittee at Uppsala University and later by the Regional
Research Ethics Board.
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Figure 1 Screening participation. Screening participation rate by
age.
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Data was analysed using the SAS software, version 9.1
[6]. Summary statistics, such as means and measures of
dispersion, were computed with traditional parametric
methods. Simple differences between the groups regard-
ing continuous data were tested using Student’s t-test or
analysis of variance, and nominal or ordinal data with
the chi-square test.
The cumulative distribution of first PHCC post-
screening follow-up appointment was analysed using
Cox’s proportional hazards regression, with the first
appointment as outcome (dependent) variable and the
group variable (screened positive or negative), age and
sex as the independent variables. Follow-up time was
computed as the number of days from screening until
outcome or end of follow up. The subjects were cen-
sored at time of death or at end of follow up, whichever
came first.
The cumulative distribution of receiving a hyperten-
sion diagnosis based on PHCC and hospital records
among subjects with no such diagnosis at screening was
analysed accordingly, with first hypertension diagnosis
as outcome and the group variable (screening positively
or negatively), age, sex, and screening systolic and dia-
stolic blood pressure as independent variables.
The numbers needed to screen (NNS) to find a new
case of hypertension, a parallel to numbers needed to
treat (NNT) in randomised clinical drug trials, was com-
puted in a similar way to NNT, as the reciprocal of the
proportion of new cases found by screening, over and
above those who would have been detected in any case
[7]. The numbers used are shown in the Results section.
All tests were two-tailed. A p-level of less than 0.05 was
set to indicate significance.
Results
Characteristics of the study population
Some characteristics of the study population are given in
Table 1. Half the population was female, mean age at
screening was 46 years, mean height 173 centimetres,
mean weight 79 kilograms, and mean body mass index
26. During the three years preceding screening, 861 sub-
jects, 74.9% of the 1,149 eligible subjects, had seen their
GP at least once, on average 3.2 times per subject.
Moreover, one (0.01%) subject had been admitted to
hospital once. During the three years following screen-
ing 925 (80.5%) subjects saw their GP at least once, on
average 3.9 times per subject, and six (0.5%) subjects
had altogether 12 admissions to hospital. Seven (0.6%)
subjects died during follow up.
The distribution of the screening systolic and diastolic
blood pressure is shown in Figure 2. The systolic blood
pressure range was 84-223 mmHg, mean 135 mmHg,
median 133 mmHg. The corresponding values for
diastolic blood pressure were 44-129 mmHg, 82 mmHg
and 81 mmHg.
Screening outcome
Out of the 1,149 subjects, 115 (10.1%) had screening
systolic blood pressure >160 mmHg, and 221 (19.2%)
had diastolic blood pressure >90 mmHg, Table 2. In all,
237 (20.6%) had systolic or diastolic blood pressure
above the cut-off point, and were therefore referred to
their PHCC. Of these subjects, 221 (93.2%) had no
hypertension diagnosis in the PHCC records or hospital
discharge data during the three years preceding the
index dental service appointment, five (2.1%) had been
subjected to a blood pressure work-up but no hyperten-
sion diagnosis was arrived at, and 11 (4.6%) had a pre-
vious hypertension diagnosis which they denied on
occasion of screening.
During the three years following screening 230 (97.1%)
of the 237 subjects referred saw a district nurse or their
GP, and had their blood pressure measured. The corre-
sponding numbers among the non-referred was 695
(76.2%), p for difference < 0.0001.
Of the referred subjects 84 (35.4%) did not receive
diagnosis of hypertension, 77 (32.5%) were subjected to
a hypertension work-up but received no hypertension
diagnosis, and 76 (32.1%) received a hypertension diag-
nosis. The corresponding numbers for those not
referred were 872 (95.6%), 14 (1.5%), and 26 (2.9%). The
difference in work-up result between referred and non-
referred subjects was highly significant (p < 0.0001).
Of the 76 subjects who received a hypertension diag-
nosis during follow up, 66 (86.8%) had no previous
Table 1 Characteristics of the study population
N Mean (SD)
or %
No. of eligible patients 1,149 100
Mean age at screening, years 1,149 46.4 (9.52)
Women, % 573 49.9
Reported height, cm 1,149 172.7 (9.23)
Reported weight, kg 1,149 78.8 (14.78)
Body mass index, kg/m
2 1,149 26.3 (3.92)
Three-year period prior to screening
GP appointments 3,639
Patients seen by GP 861 74.9
Hospital admissions 1
No. of patients admitted 1 0.1
Three-year period following screening
GP appointments 4,309
Patients seen by GP 925 80.5
Hospital admissions 12
No. of patients admitted 6 0.5
Deceased after dental screening appointment 7 0.6
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Page 3 of 7history of hypertension, two (2.6%) had a previous work
up performed but no diagnosis, and eight (10.5%) had a
previous diagnosis of hypertension.
In Figure 3 the cumulative distribution of first PHCC
follow-up appointments by day after the screening is
shown for those referred and those not referred. The
cumulative proportion of subjects seeing their GP
increased much more rapidly among referred subjects
than among not referred during the first 180 days. After
this time period the rate of increase was about the same
in the two groups, even though it occurred on a higher
level among referred. The tendency to see the GP was
affected by referral (HR 2.55, 95%CI 2.18-2.98, p <
0.0001), by age (HR 1.02, 95%CI 1.01-1.02, p < 0.0001),
and by sex (HR men to women 0.88, 95%CI 0.77-0.998,
p < 0.05).
The cumulative proportion of subjects who received a
diagnosis of hypertension among those who had no
diagnosis at screening is shown in Figure 4. Among the
referred subjects, the proportion with a diagnosis of
hypertension increased rapidly during the first few
months after the dental appointment, then levelled off.
Among the non-referred the proportion increased slowly
and successively during the three-year follow up. The
probability of receiving a diagnosis of hypertension was
affected by age (HR 1.02, 95%CI 1.001-1.02), systolic
and diastolic screening blood pressure (HR 1.03, 95%CI
1.02-1.04, and 1.08, 95%CI 1.06-1.10, respectively), but
not by sex (HR men to women 0.90, 95%CI 0.67-1.22).
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Figure 2 Screening blood pressure distribution. Distribution of screening systolic blood pressure and diastolic blood pressure.
Table 2 Results of the screening procedure and follow up
Screening result
Negative Positive
n% n %
Systolic blood pressure >160 mmHg 1,034 89.9 115 10.1
Diastolic blood pressure >90 mmHg 928 80.8 221 19.2
Systolic >160 mmHg or diastolic >90 mmHg 912 79.4 237 20.6
Hypertension history
No previous hypertension diagnosis 892 97.8 221 93.2
Previous hypertension work-up but no
diagnosis
5 0.5 5 2.1
Previous hypertension diagnosis 15 1.6 11 4.6
Subjects who saw their GP within 3 years 695 76.2 230 97.1
Blood pressure measured -*
) - 230 97.1
No hypertension diagnosis 872 95.6 84 35.4
Hypertension work-up, no diagnosis 14 1.5 77 32.5
Hypertension diagnosis established 26 2.9 76 32.1
*
) data not available.
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Figure 3 Proportions seeing GP. Cumulative percentage of those
who screened positive and negative who saw their general
practitioner during three years of follow up.
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average 51.9 (SD 6.94) years old, had a screening blood
pressure of 169.9 (SD 18.03)/101.8 (SD 9.58) mmHg,
and a first PHCC blood pressure reading of 154.1 (SD
19.89)/89.2 (SD 12.14) mmHg. The corresponding data
for those who did not receive a diagnosis were 60.9%,
48.1 (SD 9.14) years, 156.1 (SD 13.54)/96.2 (SD 6.11)
mmHg, and 136.6 (SD 12.57)/80.6 (SD 7.71) mmHg.
Of the 86 previously unknown cases of hypertension
found during follow up, 68 screened positive, yielding a
sensitivity of 79.1%, Table 3. Of the 1,037 subjects who
did not receive a diagnosis of hypertension during follow
up 879 screened negative, giving a specificity of 84.8%.
Of the 226 with no previous diagnosis of hypertension
and who screened positive, 68 received a diagnosis of
hypertension, yielding a positive predictive value of
30.1%. A Receiver Operating Characteristics curve
(ROC) analysis showed that the optimal systolic blood
pressure screening level would have been 145-150
mmHg and the diastolic level 85-90 mmHg.
Among subjects who screened negative, 18 out of 897
(2.0%) received a hypertension diagnosis during follow
up, Table 3. Assuming the same detection rate among
all the subjects screened would have given approxi-
mately 23 (2% of 1,149 subjects) subjects with new
diagnosis of hypertension if no screening had been per-
formed. With screening, 63 (86-23) new hypertensive
patients were identified, over and above those who
would have been detected in any case. NNS based on
these assumptions would then be 1/(63/1,149) = 18.2
screened to find one case.
Discussion
In this co-operative study between the dental and pri-
mary health care services every fifth patient who came
for a regular dental examination and an opportunistic
blood pressure screening had systolic blood pressure
>160 mmHg or diastolic blood pressure >90 mmHg. Of
those who screened positive almost all saw their GP for
a blood pressure follow up, and one third received a
diagnosis of hypertension within three years of screen-
ing. Screening sensitivity was 79%, specificity 85%, posi-
tive predictive value 30%, and NNS was 18.
The conditions during the blood pressure screening
performed in this study were basically the same as in
blood pressure screening performed by medical care
practitioners. The blood pressure measurement proce-
dure was standardized, with all measurements in the left
arm after at least five minutes’ rest. It has previously
been shown that the blood pressure level falls during
the first few minutes of rest but has attained a stable
level within five minutes, irrespective of blood pressure
level [8,9]. The Omron M4
® device has been tested
against manual blood pressure readings. The variability
of the readings appears to be comparable to that for
manual readings performed by different observers [10].
The strengths of this study include the fact that the
study was performed as opportunistic screening at the
dental care service, the only medical service that sees a
considerable proportion of the general public annually
or biannually, yielding a large study population at low
cost. The co-operation with the primary care services
was a prerequisite for a successful work-up of subjects
who screened positive. Other strengths include the close
monitoring of outcome, i.e., a diagnosis of hypertension
in subjects screened during follow up, with an almost
100% complete information.
The limitations include scanty clinical information
from the GP appointments, such as the hypertension
diagnosis criteria. However, we have reason to believe
that the GPs were following the national guidelines for
diagnosing high blood pressure, based on World Health
Organization (WHO) recommendations, or used some-
what higher hypertension criteria [11]. This means that
the results of this study are minimum results in the sense
that diagnostic procedures carried out strictly according
to guidelines might have yielded even better results.
It is well known that screening blood pressures tend
to be higher than pressure readings at clinics, which in
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Figure 4 Proportions being diagnosed. Cumulative percentage of
those who received a diagnosis of hypertension during three years
of follow up.
Table 3 Data for sensitivity, specificity, and predictive
value calculations
Work-up result
No hypertension
diagnosis
Hypertension
diagnosis
Total
Screening result
Negative 879 18 897
Positive 158 68 226
Total 1,037 86 1,123
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[12,13]. This is known as so called white coat hyperten-
sion and was not caused by erroneous screening blood
pressure readings. The equipment was regularly checked
by the co-operating PHCCs. In spite of the tendency to
have higher readings at screening than during work up
we chose to use the blood pressure levels indicating
hypertension as proposed by the Fourth Joint European
Societies Recommendation onP r e v e n t i o no fC o r o n a r y
Heart Disease in Clinical Practice guidelines [14], antici-
pating a considerable proportion of “false positives” or
“noise”, i.e., subjects screening positive owing to tem-
porarily high blood pressure readings.
In this case, 70% of subjects who screened positive
were false positives in the sense that they did not receive
a hypertension diagnosis during the three-year follow
up. Using a higher cut-off blood pressure level would
have yielded fewer false positives and higher specificity
but lower sensitivity. In thi ss t u d yw ec h o s eac u t - o f f
level that turned out to be close to the optimum one, as
determined in the ROC curve based analysis.
The risks associated with high blood pressure in terms
of developing various forms of cardiovascular disease
are well known and have been summarized in the
Fourth Joint European Societies Recommendation on
Prevention of Coronary Heart Disease in Clinical Prac-
tice guidelines [14]. The general idea of the guidelines is
that, all things considered, early detection and treatment
of high blood pressure is associated with a better out-
come than if the condition is detected late in its course.
Traditionally blood pressure screening, especially in
connection with scientific studies, has been performed
by special organisations. However, the participation rate
is a moderate 60%-67% and the cost of screening is high
[15]. The alternative, opportunistic screening, involves
using an existing organisation with screening cost being
marginal in relation to the total cost of the organisation.
Opportunistic screening with subsequent medical care
should preferably be performed by the primary care ser-
vice, where patient selection is low. However, the
screening must be long-term, each screening round tak-
ing up to five years to screen 80% or more of the gen-
eral population [16]. In the present study the mean
participation rate was 64%, but in the age group of most
interest in blood pressure screening, 40 years of age or
older, the participation rate was 70%-80% during the
three-year screening period, as shown in Figure 1.
The results of screening carried out at other types of
facilities, such as supermarkets [17,18] and pharmacies
[19] have been reported as successful in terms of the
number of people screened (numerator), but may imply
problems, such as handling of confidential information,
and the uncertainty of the size and geographical delinea-
tion of the underlying general population (denominator).
By screening at the dental care services, as in the pre-
sent study, a number of these problems were avoided.
Dental care is one of few medical services to which a
considerable proportion of the general population
comes for regular check-ups. In Sweden more than 80%
of the general population are seen by the dental care
services within a two-year period [3], there are no pro-
blems with handling of confidential information, and the
underlying general population can easily be determined.
In all screening activities, subjects who screen positive
must be followed up. In this study, the follow up was
carried out at the primary health care services, the coop-
erating partner. This partnership was one of the prere-
quisites for success.
Even though the study was performed in Sweden, the
results appear to be applicable to all geographical areas
with a similar structure of medical and dental services,
for instance the Nordic countries and the United
Kingdom.
Conclusions
In this co-operative project between dental and primary
care services the blood pressure screening procedure
was efficient. One fifth screened positive, the over-
whelming majority of those who screened positive came
for follow up, and one third of those who screened posi-
tive received a diagnosis of hypertension during the
three-year follow up. On average, for every 18 subjects
screened one case of hypertension was found. The pro-
cedure therefore appears to be an effective way of
detecting unknown hypertension.
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